These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 17453713

  • 1. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J, Villa A.
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [Abstract] [Full Text] [Related]

  • 2. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A.
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [Abstract] [Full Text] [Related]

  • 3. Infiltration of inflammatory cells through brain endothelium.
    Couraud PO.
    Pathol Biol (Paris); 1998 Mar; 46(3):176-80. PubMed ID: 9769913
    [Abstract] [Full Text] [Related]

  • 4. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
    McCandless EE, Klein RS.
    Expert Rev Mol Med; 2007 Jul 19; 9(20):1-19. PubMed ID: 17637110
    [Abstract] [Full Text] [Related]

  • 5. Structure and function of the blood-brain barrier.
    Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ.
    Neurobiol Dis; 2010 Jan 19; 37(1):13-25. PubMed ID: 19664713
    [Abstract] [Full Text] [Related]

  • 6. Development of the blood-brain barrier.
    Engelhardt B.
    Cell Tissue Res; 2003 Oct 19; 314(1):119-29. PubMed ID: 12955493
    [Abstract] [Full Text] [Related]

  • 7. The critical component to establish in vitro BBB model: Pericyte.
    Lai CH, Kuo KH.
    Brain Res Brain Res Rev; 2005 Dec 15; 50(2):258-65. PubMed ID: 16199092
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I, Zipp F, Infante-Duarte C.
    J Neurol Sci; 2008 Nov 15; 274(1-2):31-8. PubMed ID: 18706659
    [Abstract] [Full Text] [Related]

  • 9. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C, Alvarez JI, Prat A.
    FEBS Lett; 2011 Dec 01; 585(23):3770-80. PubMed ID: 21550344
    [Abstract] [Full Text] [Related]

  • 10. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.
    Cardoso FL, Brites D, Brito MA.
    Brain Res Rev; 2010 Sep 24; 64(2):328-63. PubMed ID: 20685221
    [Abstract] [Full Text] [Related]

  • 11. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C, Förster C.
    J Neuroimmunol; 2006 Oct 24; 179(1-2):37-45. PubMed ID: 16884785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.
    Prat A, Biernacki K, Antel JP.
    J Autoimmun; 2005 Mar 24; 24(2):119-24. PubMed ID: 15829404
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Current concepts of blood-brain barrier development.
    Liebner S, Czupalla CJ, Wolburg H.
    Int J Dev Biol; 2011 Mar 24; 55(4-5):467-76. PubMed ID: 21769778
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.